Original language | English |
---|---|
Pages (from-to) | 1694-1697 |
Number of pages | 4 |
Journal | Blood |
Volume | 137 |
Issue number | 12 |
Early online date | 10 Nov 2020 |
DOIs | |
Publication status | Published - 25 Mar 2021 |
Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cells
Diana Hanekamp, Lok Lam Ngai, Jeroen J. W. M. Janssen, Arjan van de Loosdrecht, Gert J. Ossenkoppele, Jacqueline Cloos*
*Corresponding author for this work
Research output: Contribution to journal › Letter › Academic › peer-review